GCOM1 (POLR2M) (NM_015532) Human Tagged ORF Clone Lentiviral Particle
CAT#: RC219621L3V
- LentiORF®
Lenti ORF particles, POLR2M (Myc-DDK tagged) - Human glutamate receptor, ionotropic, N-methyl D-aspartate-like 1A (GRINL1A), transcript variant 1, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 8,930.00
货期*
详询
规格
Product images
经常一起买 (3)
Specifications
Product Data | |
Product Name | GCOM1 (POLR2M) (NM_015532) Human Tagged ORF Clone Lentiviral Particle |
Synonyms | GCOM1; Gdown; Gdown1; GRINL1A |
Vector | pLenti-C-Myc-DDK-P2A-Puro |
ACCN | NM_015532 |
ORF Size | 1104 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(RC219621).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | NM_015532.3 |
RefSeq Size | 4139 bp |
RefSeq ORF | 1107 bp |
Locus ID | 81488 |
Protein Families | Druggable Genome, Ion Channels: Other |
MW | 41.6 kDa |
Gene Summary | This gene encodes a subunit of a specific form of RNA polymerase II termed Pol II(G). The encoded protein may act as a negative regulator of transcriptional activation by the Mediator complex. Alternative splicing results in multiple transcript variants. There is a pseudogene for this gene on chromosome 4. Readthrough transcription between this gene and the neighboring upstream gene MYZAP (myocardial zonula adherens protein) is represented with GeneID 145781. [provided by RefSeq, Oct 2013] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
You may also need
Customer
Reviews
Loading...